Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Triple Therapy for H. Pylori with Peptic Ulcer Complications
NCT04432233Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of esomeprazole, metronidazole, levofloxacin in Helicobacter pylori infection, Peptic ulcer disease (PUD), sponsored by Shanghai Jiao Tong University School of Medicine. Status: unknown.
02
Drugs
esomeprazolemetronidazolelevofloxacin
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)
Beyond the preview
Go deeper on NCT04432233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04432233.